Healthcare
Live Price
Offline$12.05
+0.00% today
1Y Change
+138.14%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 253 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RemeGen Co., Ltd. (REGMF) is a Healthcare stock with a market cap of $71.56B and listed on OTC. The stock last traded around $12.05 and up 138.1% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +85.2%, EPS growth of +146.2%, a dividend yield of 0.0%. What stands out right now is revenue +85.2%, EPS +146.2%, free cash flow +90.3% with operating margin 28.0% and ROIC 15.5%. Valuation already assumes a fairly strong business story at P/E 56.0 and price/sales 21.2. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines REGMF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
REGMF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
REGMF Max Drawdown
-18.11%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for REGMF and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.